Food giant Nestle is aiming to capitalize on the surge in use of anti-obesity medications like Ozempic and Wegovy. The company just unveiled a new line of frozen meals and snacks specifically marketed to people following the popular injectable weight loss drug regimens.
The “Ozempic Diet Delights” frozen entrees and snack bites promise low-calorie, high-protein options tailored to meet the dietary needs of those using the powerful GLP-1 medications. Packaging highlights easy portable snacks to curb cravings while continuing weight loss.
It’s the latest attempt by a major food company to break into the lucrative weight loss market exploding around the new generation of anti-obesity drugs. Rivals like Kraft-Heinz and Conagra are also rumored to be developing similar product lines.
With Ozempic and Wegovy potentially reaching billions of users globally, Nestle sees an opportunity to cross-sell diet-friendly frozen foods to those already accustomed to injectable therapies and rigorous eating plans.
However, some health experts criticize the move, arguing ultra-processed frozen meals undermine sustainable dietary habits needed to keep weight off after stopping the medication.
